Effort-based decision-making paradigms for clinical trials in schizophrenia: Part 2 - External validity and correlates

Schizophrenia Bulletin

Volumn 41, Issue 5, 2015, Pages 1055-1065

  Horan, William P ^a,b   Felice Reddy, L ^a,b   Barch, Deanna M ^c   Buchanan, Robert W ^d   Dunayevich, Eduardo ^e   Gold, James M ^d   Marder, Steven R ^a,b   Wynn, Jonathan K ^a,b   Young, Jared W ^f,g   Green, Michael F ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e AMGEN INC   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Decision making; Effort; Functional outcome; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COGNITION; DECISION MAKING; FAMILY; FEMALE; FUNCTIONAL ASSESSMENT; GRIP STRENGTH; HAND GRIP; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; NEGATIVE SYNDROME; PERCEPTION; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; REWARD; SCHIZOPHRENIA; SELF REPORT; SOCIAL NETWORK; TASK PERFORMANCE; WORK; DEVICES; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMETRY; PSYCHOMOTOR PERFORMANCE; REPRODUCIBILITY;

ADULT; CLINICAL TRIALS AS TOPIC; DECISION MAKING; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTIVATION; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; REPRODUCIBILITY OF RESULTS; REWARD; SCHIZOPHRENIA;

EID: 84943186168     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbv090     Document Type: Article

References (40)

1. Young JW, Markou A. Translational rodent paradigms to investigate neuromechanisms underlying behaviors relevant to amotivation and altered reward processing in schizophrenia. Schizophr Bull.
2. Reddy LR, Horan WP, Barch D, et al. Effort-based decision making paradigms for clinical trials in schizophrenia: part 1 - psychometric characteristics of five paradigms. Schizophr Bull.
3. Green MF, Horan WP, Barch DM, Gold JM. Effort-based decision making: a novel approach for assessing motivation in schizophrenia. Schizophr Bull.
4. Barch DM, Treadway MT, Schoen N. Effort, anhedonia, and function in schizophrenia: reduced effort allocation predicts amotivation and functional impairment. J Abnorm Psychol. 2014;123:387-397.
5. Gold JM, Strauss GP, Waltz JA, Robinson BM, Brown JK, Frank MJ. Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol Psychiatry. 2013;74:130-136.
6. Hartmann MN, Hager OM, Reimann AV, et al. Apathy but not diminished expression in schizophrenia is associated with discounting of monetary rewards by physical effort. Schizophr Bull. 2015;41:503-512.
7. Treadway MT, Peterman JS, Zald DH, Park S. Impaired effort allocation in patients with schizophrenia. Schizophr Res. 2015;161:382-385.
8. Wolf DH, Satterthwaite TD, Kantrowitz JJ, et al. Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures. Schizophr Bull. 2014;40:1328-1337.
9. Docx L, de la Asuncion J, Sabbe B, et al. Effort discounting and its association with negative symptoms in schizophrenia. Cogn Neuropsychiatry. 2015;20:172-185.
10. Fervaha G, Graff-Guerrero A, Zakzanis KK, Foussias G, Agid O, Remington G. Incentive motivation deficits in schizophrenia reflect effort computation impairments during cost-benefit decision-making. J Psychiatr Res. 2013;47:1590-1596.
11. Gold JM, Kool W, Botvinick MM, Hubzin L, August S, Waltz JA. Cognitive effort avoidance and detection in people with schizophrenia. Cogn, Affect Behav Neurosci. 2015;15:145-154.
12. First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin L. Structured Clinical Interview for DSM-IV Axis II Personality Disorders. New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1996.
13. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition. New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1997.
14. Treadway MT, Buckholtz JW, Schwartzman AN, Lambert WE, Zald DH. Worth the 'EEfRT'? The effort expenditure for rewards task as an objective measure of motivation and anhedonia. PLoS One. 2009;4:e6598.
15. Kring AM, Gur RE, Blanchard JJ, Horan WP, Reise SP. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation. Am J Psychiatry. 2013;170:165-172.
16. Axelrod BN, Goldman RS, Alphs LD. Validation of the 16-item Negative Symptom Assessment. J Psychiatr Res. 1993;27:253-258.
17. Kay SR, Fiszbein, A., Opler, L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-271.
18. Heinrichs DW, Hanlon TE, Carpenter WT. The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull. 1984;10:388-398.
19. Nakagami E, Xie B, Hoe M, Brekke JS. Intrinsic motivation, neurocognition and psychosocial functioning in schizophrenia: testing mediator and moderator effects. Schizophr Res. 2008;105:95-104.
20. Choi J, Choi KH, Felice Reddy L, Fiszdon JM. Measuring motivation in schizophrenia: is a general state of motivation necessary for task-specific motivation? Schizophr Res. 2014;153:209-213.
21. Bell MD, Choi KH, Dyer C, Wexler BE. Benefits of cognitive remediation and supported employment for schizophrenia patients with poor community functioning. Psychiatr Serv. 2014;65:469-475.
22. Gard DE, Fisher M, Garrett C, Genevsky A, Vinogradov S. Motivation and its relationship to neurocognition, social cognition, and functional outcome in schizophrenia. Schizophr Res. 2009;115:74-81.
23. McPheeters HL. Statewide mental health outcome evaluation: a perspective of two southern states. Community Ment Health J. 1984;20:44-55.
24. Carver CS, Whilte TL. Behavioral inhibition, behavioral activation, and affective responses to impending reward and punishment: the BIS/BAS scales. J Pers Soc Psychol. 1994;67:319-333.
25. Grant PM, Beck AT. Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia. Schizophr Bull. 2009;35:798-806.
26. Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165:203-213.
27. Harvey PD, Koren D, Reichenberg A, Bowie CR. Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr Bull. 2006;32:250-258.
28. Strauss GP, Morra LF, Sullivan SK, Gold JM. The role of low cognitive effort and negative symptoms in neuropsychological impairment in schizophrenia. Neuropsychology. 2015;29:282-291.
29. Strauss GP, Waltz JA, Gold JM. A review of reward processing and motivational impairment in schizophrenia. Schizophr Bull. 2014;40(Suppl 2):S107-S116.
30. Meyer EC, Carrión RE, Cornblatt BA, et al; NAPLS group. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophr Bull. 2014;40:1452-1461.
31. Bratti IM, Kane JM, Marder SR. Chronic restlessness with antipsychotics. Am J Psychiatry. 2007;164:1648-1654.
32. Goldstein RZ, Tomasi D, Alia-Klein N, et al. Subjective sensitivity to monetary gradients is associated with frontolimbic activation to reward in cocaine abusers. Drug Alcohol Depend. 2007;87:233-240.
33. Martin-Soelch C, Chevalley AF, Kunig AF, et al. Changes in reward-induced brain activation in opiate addicts. Eur J Neurosci. 2001;14:1360-1368.
34. Bender R, Lange S. Adjusting for multiple testing - when and how? J Clin Epidemiol. 2001;54:343-349.
35. Green MF, Hellemann G, Horan WP, Lee J, Wynn JK. From perception to functional outcome in schizophrenia: modeling the role of ability and motivation. Arch Gen Psychiatry. 2012;69:1216-1224.
36. Ventura J, Wood RC, Hellemann GS. Symptom domains and neurocognitive functioning can help differentiate social cognitive processes in schizophrenia: a meta-analysis. Schizophr Bull. 2013;39:102-111.
37. Randall PA, Lee CA, Podurgiel SJ, et al. Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms. Int J Neuropsychopharmacol. 2014;18.
38. Randall PA, Pardo M, Nunes EJ, et al. Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. PLoS One. 2012;7:e47934.
39. Salamone JD, Correa M, Nunes EJ, Randall PA, Pardo M. The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond. J Exp Anal Behav. 2012;97:125-146.
40. Ward RD, Simpson EH, Richards VL, et al. Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia. Neuropsychopharmacology. 2012;37:1699-1707.